secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2024-08-28T23:59:59+00:00
Accession:  0001104659-24-093660
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics furnishes investor presentation with no new material facts disclosed
--------------------------------------------------------------------------------

- Filed an investor presentation under Item 7.01 on August 28, 2024.
- Presentation cover titled 'Targeting Amyloid Beta Oligomers: A Disruptive Approach to the Treatment of Alzheimer’s Disease'.
- No specific financial or clinical data from the presentation are included in the filing.
- Presentation is furnished, not filed, and not incorporated by reference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924093660/0001104659-24-093660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924093660/tm2422819d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-093660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer